Search Results - "WINCHESTER, G. A"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Use of Microsphere Technology for Targeted Delivery of Rifampin to Mycobacterium tuberculosis-Infected Macrophages by BARROW, E. L. W, WINCHESTER, G. A, STAAS, J. K, QUENELLE, D. C, BARROW, W. W

    Published in Antimicrobial Agents and Chemotherapy (01-10-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice by QUENELLE, D. C, STAAS, J. K, WINCHESTER, G. A, BARROW, E. L. W, BARROW, W. W

    Published in Antimicrobial agents and chemotherapy (01-05-1999)
    “…Rifampin is a first-line drug useful in the treatment of tuberculosis. By using biocompatible polymeric excipients of lactide and glycolide copolymers, two…”
    Get full text
    Journal Article
  3. 3

    Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with Isoniazid by QUENELLE, Debra C, WINCHESTER, Gary A, STAAS, Jay K, BARROW, Esther L. W, BARROW, William W

    Published in Antimicrobial Agents and Chemotherapy (01-06-2001)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Sustained release characteristics of rifampin-loaded microsphere formulations in nonhuman primates by Quenelle, Debra, Winchester, Gary A, Staas, Jay K, Hoskins, Darrel E, Barrow, Esther W, Barrow, William W

    Published in Drug delivery (01-01-2004)
    “…Controlled release rifampin-loaded microspheres were evaluated for the first time in nonhuman primates. Animals received either 2.0 g of a large formulation…”
    Get more information
    Journal Article